Considering the proven association of SIRT6 with glycolysis and that MZF1 is an upstream transcription factor of SIRT6, we hypothesized that mitoAMPK can inhibit the Warburg effect via the MZF1–SIRT6 pathway in NSCLC. Here, SIRT6 is linked to non-small cell lung carcinoma.